Biofrontera Inc. (NASDAQ:BFRI) Sees Large Decline in Short Interest

Biofrontera Inc. (NASDAQ:BFRI) was the recipient of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 316,600 shares, a decrease of 30.7% from the October 31st total of 457,100 shares. Based on an average daily trading volume, of 2,780,000 shares, the short-interest ratio is currently 0.1 days. Currently, 7.8% of the company’s stock are short sold.

Analyst Ratings Changes

Separately, Benchmark reaffirmed a “buy” rating and set a $7.00 price objective on shares of Biofrontera in a research report on Friday, November 15th.

Biofrontera Trading Down 9.1 %

Shares of NASDAQ BFRI traded down $0.09 during mid-day trading on Friday, reaching $0.90. The company had a trading volume of 451,354 shares, compared to its average volume of 1,042,479. The firm has a 50 day simple moving average of $0.94 and a two-hundred day simple moving average of $1.04. Biofrontera has a 52-week low of $0.61 and a 52-week high of $4.00. The stock has a market cap of $6.98 million, a P/E ratio of -0.40 and a beta of 0.50.

Biofrontera Company Profile

Biofrontera Inc, a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.